Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-358491
Filing Date
2013-09-05
Accepted
2013-09-05 17:03:56
Documents
5
Period of Report
2013-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d591577d8ka.htm 8-K/A 676306
2 EX-99.1 d591577dex991.htm EX-99.1 240871
3 EX-99.3 d591577dex993.htm EX-99.3 132545
5 GRAPHIC g591577001.jpg GRAPHIC 24257
6 filename6.htm CORRESP 40738
  Complete submission text file 0001193125-13-358491.txt   1125861
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-178230 | Film No.: 131080985
SIC: 2834 Pharmaceutical Preparations